Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm delivers IND to US FDA for Pivotal OA Program

Mar 26, 2021 at 3:01 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment